Skip to main content

Advertisement

SpringerLink
Log in

Temozolomide for Pediatric High-Grade Gliomas

  • Clinical Trial Report
  • Published:
Current Neurology and Neuroscience Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114:97–109.

    Article  PubMed  Google Scholar 

  2. MacDonald TJ, Aguilera D, Kramm CM. Treatment of high-grade glioma in children and adolescents. Neuro-Oncology. 2011;13(10):1049–58.

    Article  PubMed  CAS  Google Scholar 

  3. Sposto R, Ertel U, Jenkin RD, et al. The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: results of a randomized trial. A report from the Children’s Cancer Study Group. J Neurooncol. 1989;7:165–77.

    Article  PubMed  CAS  Google Scholar 

  4. Pollack IF, Boyett JM, Yates AF, et al. The influence of central review on outcome associations in childhood malignant gliomas: results from the CCG-945 experience. Neuro-Oncology. 2003;5:197–207.

    Article  PubMed  Google Scholar 

  5. Finlay JL, Boyett JM, Yates AJ, et al. Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Children’s Cancer Group. J Clin Oncol. 1995;13:112–23.

    PubMed  CAS  Google Scholar 

  6. Stupp R, Mason SP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352:987–96.

    Article  PubMed  CAS  Google Scholar 

  7. Boyett J, Yates A, Gilles F, et al. When is a high-grade astrocytoma (HGA) not a HGA? results of a central review of 226 cases of anaplastic astrocytoma (AA), glioblastoma multiforme (GBM), and other-HA (OTH-HGA) by five neuropathologists. Proc Am Soc Clin Oncol. 1998;17:526a.

    Google Scholar 

  8. Hegi MD, Diserens AC, Gorlie T, et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med. 2005;352:997–1003.

    Article  PubMed  CAS  Google Scholar 

  9. CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2004–2006. Central Brain Tumor Registry of the United States, Hinsdale, IL. Website: www.cbtrus.org. CBTRUS; 2010.

  10. Liang ML, Ma J, Ho M, et al. Tyrosine kinase expression in pediatric high grade astrocytoma. J Neurooncol. 2008;87:247–53.

    Article  PubMed  Google Scholar 

  11. Thorarinsdottir HK, Santi M, McCarter R, et al. Protein expression of platelet-derived growth factor receptor correlates with malignant histology and PTEN with survival in childhood gliomas. Clin Cancer Res. 2008;14:3386–94.

    Article  PubMed  CAS  Google Scholar 

  12. Pollack IF, Hamilton RL, Sobol RW, et al. IDH1 mutations are common in malignant gliomas arising in adolescents: a report from the Children’s Oncology Group. Childs Nerv Syst. 2011;27:87–94.

    Article  PubMed  Google Scholar 

  13. Pollack IF, Hamilton RL, Sobol RW, et al. O6-methylguanine-DNA methyltransferase expression strongly correlates with outcome in childhood malignant gliomas: results from the CCG-945 cohort. J Clin Oncol. 2006;24:3431–7.

    Article  PubMed  CAS  Google Scholar 

  14. Cohen KJ, Heideman RL, Zhou T, et al. Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: a report from the Children’s Oncology Group. Neuro-Oncology. 2011;13(4):410–6.

    Article  PubMed  Google Scholar 

  15. Broniscer A, Gajjar A. Supratentorial high-grade astrocytoma and diffuse brainstem glioma: two challenges for the pediatric oncologist. Oncologist. 2004;9:197–206.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Center for Neuroscience and Behavioral Medicine, Children’s National Medical Center, Gilbert Neurofibromatosis Institute, Brain Tumor Institute, 111 Michigan Avenue, NW, Washington, DC, 20010, USA

    Roger J. Packer

Authors
  1. Roger J. Packer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Roger J. Packer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Packer, R.J. Temozolomide for Pediatric High-Grade Gliomas. Curr Neurol Neurosci Rep 12, 111–113 (2012). https://doi.org/10.1007/s11910-012-0250-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11910-012-0250-2

Keywords

Search

Navigation